Pauline Brice Selected Research

Hodgkin Disease (Hodgkin's Disease)

1/2022	Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study.
1/2022	Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA).
1/2022	Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study.
10/2021	Classical Hodgkin lymphoma.
1/2021	Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMT.
1/2021	Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study.
1/2020	Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis.
11/2019	Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma.
10/2019	Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.
6/2019	Unconventional immune-related phenomena observed using 18F-FDG PET/CT in Hodgkin lymphoma treated with anti PD-1 monoclonal antibodies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pauline Brice Research Topics

Disease

58	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 01/2002
27	Lymphoma (Lymphomas) 10/2021 - 07/2002
21	Neoplasms (Cancer) 07/2020 - 11/2003
21	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2019 - 10/2006
6	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2017 - 07/2009
5	B-Cell Lymphoma (Lymphoma, B Cell) 11/2019 - 01/2002
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 02/2004
4	Disease Progression 11/2019 - 01/2008
3	Primary Ovarian Insufficiency 01/2016 - 01/2012
3	T-Cell Lymphoma (Lymphoma, T Cell) 10/2012 - 01/2002
2	Fever (Fevers) 01/2021 - 01/2013
2	Infections 01/2020 - 03/2003
2	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 03/2014
2	Febrile Neutropenia 01/2018 - 04/2011
2	Peripheral Nervous System Diseases (PNS Diseases) 12/2017 - 03/2014
2	Hypersensitivity (Allergy) 06/2017 - 01/2005
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 06/2017 - 03/2014
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2016 - 08/2010
2	Anemia 01/2016 - 11/2015
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2015 - 01/2013
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2011 - 01/2008
1	Ototoxicity 01/2021
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 11/2019
1	Infertility (Sterility) 01/2019
1	Polyradiculoneuropathy (Polyradiculoneuritis) 01/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018
1	Neutropenia 01/2018
1	Lymphadenopathy 10/2017
1	Immediate Hypersensitivity 06/2017
1	Kaposi Sarcoma (Kaposi's Sarcoma) 06/2017
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 03/2016
1	HIV Infections (HIV Infection) 11/2015
1	Multiple Myeloma 11/2015
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 11/2015
1	Primary Cutaneous Anaplastic Large Cell Lymphoma 09/2015

Drug/Important Bio-Agent (IBA)

27	Rituximab (Mabthera)FDA Link 11/2019 - 01/2002
15	Brentuximab VedotinIBA 01/2022 - 06/2012
15	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 02/2004
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 02/2004
9	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 03/2005
9	Prednisone (Sone)FDA LinkGeneric 01/2019 - 02/2004
9	Vincristine (Oncovin)FDA LinkGeneric 01/2019 - 02/2004
8	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022 - 06/2006
6	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 04/2011
5	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 04/2011
5	InterferonsIBA 07/2013 - 10/2006
4	pembrolizumabIBA 01/2020 - 07/2017
3	NivolumabIBA 01/2022 - 01/2017
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 01/2002
3	Monoclonal AntibodiesIBA 06/2019 - 12/2008
3	Procarbazine (Matulane)FDA Link 01/2019 - 06/2006
3	liposomal doxorubicin (Doxil)FDA Link 06/2017 - 09/2013
3	AntigensIBA 01/2014 - 01/2006
3	Immunoglobulin G (IgG)IBA 01/2014 - 01/2006
2	EnzymesIBA 01/2021 - 04/2009
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 08/2010
2	ibrutinibIBA 07/2020 - 10/2015
2	Bendamustine Hydrochloride FDA Link 10/2018 - 11/2013
2	Lenalidomide (CC 5013)FDA Link 01/2018 - 11/2015
2	Hemoglobins (Hemoglobin)IBA 10/2017 - 01/2013
2	Pharmaceutical PreparationsIBA 06/2017 - 01/2016
2	Alkylating AgentsIBA 12/2016 - 01/2003
2	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2016 - 09/2010
2	Ifosfamide FDA LinkGeneric 10/2016 - 04/2011
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2016 - 03/2013
2	Triptorelin Pamoate (Trelstar)FDA Link 01/2016 - 03/2013
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2016 - 01/2013
2	Biological ProductsIBA 01/2016 - 11/2014
2	Gemcitabine FDA Link 07/2015 - 03/2008
2	CytokinesIBA 11/2013 - 05/2007
2	Prednisolone (Predate)FDA LinkGeneric 07/2013 - 07/2008
2	Teniposide (VM 26)FDA Link 07/2008 - 10/2006
2	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 06/2006 - 01/2002
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2020
1	romidepsin (FK228)FDA Link 11/2019
1	Histocompatibility Antigens Class IIIBA 10/2019
1	AntibodiesIBA 10/2019
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	Peptides (Polypeptides)IBA 10/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2019
1	ParaffinIBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	1-dodecylpyridoxal (PLD)IBA 06/2017
1	Norethindrone (Norethisterone)FDA LinkGeneric 01/2016
1	Vinorelbine (Navelbine)FDA LinkGeneric 07/2015

Therapy/Procedure

35	Therapeutics 10/2021 - 01/2002
32	Drug Therapy (Chemotherapy) 10/2021 - 01/2002
27	Stem Cell Transplantation 01/2022 - 01/2002
8	Radiotherapy 10/2021 - 03/2005
7	Salvage Therapy 01/2021 - 01/2002
4	Transplantation 11/2019 - 09/2007
3	Combination Drug Therapy (Combination Chemotherapy) 10/2016 - 08/2010
3	Aftercare (After-Treatment) 12/2009 - 07/2002
2	Immunotherapy 01/2018 - 12/2016
2	Induction Chemotherapy 01/2018 - 08/2005
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Time-to-Treatment 07/2020
1	Homologous Transplantation 01/2017
1	Cell Transplantation 01/2017